September 26, 2025
Bayer AG shareholders have asked a California federal judge to give final approval of its $38 million settlement with the German multinational to end claims it downplayed litigation risks related to the weedkiller Roundup, saying the deal, which seeks over $10 million in attorney fees, is fair.
A hearing for the motions is set for Oct. 30. The parties notified the court that they had reached a settlement in the case in February, and the deal was preliminarily approved in June, according to the suit’s docket.
U.S. District Judge Richard Seeborg said the deal appeared to be “fair, reasonable and adequate” when initially approving the deal in June.
. . .
Counsel for the investors declined to comment on the suit Friday.
The investors are represented by Carol V. Gilden, Steven J. Toll, Christopher Lometti and Benjamin F. Jackson of Cohen Milstein Sellers & Toll PLLC and Nicole Lavallee and Alexander S. Vahdat of Berman Tabacco.
Read Bayer Investors Seek Final OK Of $38M Settlement, Atty Fees.